How much improvement in functioning is considered important by patients with active disease modifying anti-rheumatic drug refractory rheumatoid arthritis

被引：0
|
作者：
Singh, A [1 ]
Sato, R [1 ]
Wanke, L [1 ]
机构：
[1] Hlth Outcomes Assessment, Thousand Oaks, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2003年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：108 / 108
页数：1
相关论文
共 50 条
  • [1] DISEASE MODIFYING ANTI-RHEUMATIC DRUG ADHERENCE IN RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS
    Ayano, Nakayama
    Bruce, Shadbolt
    Allison, Tong
    Kathleen, Tymms
    Chandima, Perera
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 17 - 17
  • [2] SUSTAINABILITY OF RESPONSE TO UPADACITINIB AMONG PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS REFRACTORY TO BIOLOGICAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
    van Vollenhoven, Ronald
    Hall, Stephen
    Wells, Alvin F.
    Meerwein, Sebastian
    Song, Yanna
    Suboticki, Jessica L.
    Fleischmann, Roy
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 29 - 30
  • [3] Sustainability of Response to Upadacitinib Among Patients with Active Rheumatoid Arthritis Refractory to Biological Disease-Modifying Anti-Rheumatic Drugs
    van Vollenhoven, Ronald
    Hall, Stephen
    Wells, Alvin
    Meerwein, Sebastian
    Song, Yanna
    Suboticki, Jessica
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3534 - 3536
  • [4] SUSTAINABILITY OF RESPONSE TO UPADACITINIB AMONG PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS REFRACTORY TO BIOLOGICAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS
    Van Vollenhoven, R.
    Hall, S.
    Wells, A. F.
    Meerwein, S.
    Song, Y.
    Suboticki, J.
    Fleischmann., R. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1290 - 1291
  • [5] Effect of glucocorticoids combined with disease modifying anti-rheumatic drugs on the improvement of symptoms in patients with rheumatoid arthritis
    Si, Lulu
    Jin, Yunyan
    Zhao, Dongni
    Yu, Lixia
    Cao, Huankun
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2022, 38 (04) : 976 - 980
  • [6] IMPROVEMENT OF NUTRITIONAL CONDITIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS STARTING FIRST DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    Kobayashi, D.
    Ito, S.
    Hasegawa, E.
    Narita, I.
    Nakazono, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 927 - 927
  • [7] Is cholecalciferol a potential disease-modifying anti-rheumatic drug for the management of rheumatoid arthritis?
    Bellan, M.
    Andreoli, L.
    Nerviani, A.
    Piantoni, S.
    Avanzi, G. C.
    Soddu, D.
    Hayden, E.
    Pirisi, M.
    Sainaghi, P. P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (02) : 343 - 349
  • [8] Effectiveness of disease modifying anti-rheumatic drug risk communication in rheumatoid arthritis.
    Martin, Richard W.
    McIntosh, Barbara A.
    Swartz, Timothy J.
    Head, Andrew J.
    Fiechtner, Justus J.
    Rene, Jonathan
    Holmes-Rovner, Margaret
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S369 - S369
  • [9] How much improvement in pain is considered important by patients with active psoriatic arthritis
    Mease, PJ
    Ganguly, R
    Wanke, L
    Yu, E
    Singh, A
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 431 - 431
  • [10] ADVERSE DRUG REACTIONS ASSOCIATED WITH THE USE OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Machado, J.
    Ruiz, A.
    Machado-Duque, M.
    VALUE IN HEALTH, 2015, 18 (03) : A153 - A153
12345